What is BioLife Solutions's D&A?

BioLife Solutions (BLFS) reported D&A of $374K in Q1 2026.

How has BioLife Solutions's D&A changed year-over-year?

BioLife Solutions's D&A decreased by 45.2% year-over-year, from $682K to $374K.

What is the long-term trend for BioLife Solutions's D&A?

Over 4 years (2021 to 2025), BioLife Solutions's D&A has grown at a -16.6% compound annual growth rate (CAGR), from $4.66M to $2.25M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

BioLife Solutions BLFS D&A

D&A at other companies

DanaherDHR

$193M+6.6%

AzentaAZTA

$14M+0.4%

LeMaitre VascularLMAT

$2.62M+2.8%

TEC

Bio-TechneTECH

$24.17M-12.3%

CryoPort, Inc.CYRX

$6.4M-16.3%

RevvityRVTY

$105.06M+7.8%

Other financials

Income statement

See full

Revenue$27.5M+24.7%

Gross profit$17.5M+18.2%

Operating income$27.0K+105%

Net income$1.2M+365%

EPS (diluted)$0.02—

Balance sheet

See full

Cash & equivalents$22.8M-65.9%

Total debt$17.4M-35.6%

Total equity$372.2M+5.6%

Total assets$400.9M+1.5%

Cash flow

See full

Operating cash flow-$491.0K-128%

CapEx$167.0K-4.6%

Free cash flow-$658.0K-142%

Valuation

See full

Market cap$1.25B+33.1%

Enterprise value$1.24B+38.1%

P/S12.5×+0.5×

Profitability

See full

Gross margin66.9%—

Operating margin-16.7%—

Net margin-68.7%—

FCF margin-15.9%+18.7pp

Returns & leverage

See full

Return on equity-14.5%-4.7pp

Debt / equity0×0.0×

Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioLife Solutions's D&A?: BioLife Solutions (BLFS) reported D&A of $374K in Q1 2026.
How has BioLife Solutions's D&A changed year-over-year?: BioLife Solutions's D&A decreased by 45.2% year-over-year, from $682K to $374K.
What is the long-term trend for BioLife Solutions's D&A?: Over 4 years (2021 to 2025), BioLife Solutions's D&A has grown at a -16.6% compound annual growth rate (CAGR), from $4.66M to $2.25M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.